| Factor Information | |
|---|---|
| Data ID | 2246 |
| Factor | Ischemic time >4 hours |
| Description | The only significant predictor of death in the CHD group was donor organ ischemic time >4 hours (HR 13.26, 95% CI 1.3 to 132.2, p = 0.028). |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | The purpose of this study was to evaluate survival outcomes after heart transplantation in a contemporary cohort of adults with CHD and to identify risk factors for mortality that may help guide recipient and donor selection. |
| p Value | <0.05 |
| HR | >6.0 |
| Conclusion | The only significant predictor of death in the CHD group was donor organ ischemic time >4 hours (HR 13.26, 95% CI 1.3 to 132.2, p = 0.028). |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 593 |
| CHD Type | isolated CHD |
| CHD Subtype | TGA/VSD/ASD/TOF/other |
| Reference | |
|---|---|
| PMID | 23474360 |
| Year | 2013 |
| Title | Heart transplantation for adults with congenital heart disease: results in the modern era. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | Database | |
| Region | Pennsylvania,USA | |
| Method | Uni- andmultivariateanalyses | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | Heart transplantation(HT) | |
| Group | CHD(Treatment) | N/A(Control) |
| Number | 19 | N/A |
| Age | 39.4 ± 13 years | N/A |
| Gender (Male: Female) | 12:7 | N/A |
| Marker Level | N/A | N/A |
